Eric Fink - Net Worth and Insider Trading
Eric Fink Net Worth
The estimated net worth of Eric Fink is at least $353,477 dollars as of 2024-04-19. Eric Fink is the Chief Human Resources Officer of Global Blood Therapeutics Inc and owns about 5,161 shares of Global Blood Therapeutics Inc (GBT) stock worth over $353,477. Details can be seen in Eric Fink's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric Fink has not made any transactions after 2021-05-10 and currently still holds the listed stock(s).
Transaction Summary of Eric Fink
Eric Fink Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Fink owns 1 companies in total, including Global Blood Therapeutics Inc (GBT) .
Click here to see the complete history of Eric Fink’s form 4 insider trades.
Insider Ownership Summary of Eric Fink
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GBT | Global Blood Therapeutics Inc | 2021-05-10 | Chief Human Resources Officer |
Eric Fink Latest Holdings Summary
Eric Fink currently owns a total of 1 stock. Eric Fink owns 5,161 shares of Global Blood Therapeutics Inc (GBT) as of May 10, 2021, with a value of $353,477.
Latest Holdings of Eric Fink
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GBT | Global Blood Therapeutics Inc | 2021-05-10 | 5,161 | 68.49 | 353,477 |
Holding Weightings of Eric Fink
Eric Fink Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Fink has made a total of 3 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Global Blood Therapeutics Inc is the acquisition of 500 shares on May 10, 2021, which cost Eric Fink around $18,980.
Insider Trading History of Eric Fink
- 1
Eric Fink Trading Performance
GuruFocus tracks the stock performance after each of Eric Fink's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Fink is -17.03%. GuruFocus also compares Eric Fink's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Fink within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Fink's insider trading performs compared to the benchmark.
Performance of Eric Fink
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.21 | -17.03 | -13.02 | -35.36 | ||
| Relative Return to S&P 500(%) | 10 | -22.96 | -23.96 | -30.89 |
Eric Fink Ownership Network
Ownership Network List of Eric Fink
Ownership Network Relation of Eric Fink
Eric Fink Owned Company Details
What does Global Blood Therapeutics Inc do?
Who are the key executives at Global Blood Therapeutics Inc?
Eric Fink is the Chief Human Resources Officer of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .
Global Blood Therapeutics Inc (GBT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Global Blood Therapeutics Inc Insider Transactions
Eric Fink Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Fink. You might contact Eric Fink via mailing address: C/o Global Blood Therapeutics, Inc. 171 Oyster Point Blvd., Suite 300 South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
